1. Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection. (6th July 2020) Authors: Bontempi, I.; Leal, K.; Prochetto, E.; Díaz, G.; Cabrera, G.; Bortolotti, A.; Morbidoni, H. R.; Borsuk, S.; Dellagostin, O.; Marcipar, I. Journal: Clinical and experimental immunology Issue: Volume 201:Number 3(2020) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗